MUC4 Is a Novel Prognostic Factor of Intrahepatic Cholangiocarcinoma-Mass Forming Type

Hiroaki Shibahara, Shugo Tamada, Michiyo Higashi, Masamichi Goto, Surinder Kumar Batra, Michael A Hollingsworth, Kohzoh Imai, Suguru Yonezawa

Research output: Contribution to journalArticle

102 Citations (Scopus)

Abstract

Complete surgical resection of the tumor is the sole approach to improve the cure rate of patients with intrahepatic cholangiocarcinoma-mass forming type (ICC-MF). Although patients are treated by curative resection, many of them show poor outcome. Mucin (MUC)4 expression has been implicated as a marker for diagnosis and progression of pancreatic adenocarcinomas, but there is no study of the relationship between MUC4 expression and patient's prognosis in ICC-MF. In the present study, we examined the expression profile of MUC4 in ICC-MF tissue from 27 patients using immunohistochemistry. MUC4 was expressed in the carcinoma tissues of 10 (37%) of the 27 ICC-MF tumors, whereas it was not expressed in normal liver tissue. Because MUC4 is an intramembrane ligand for receptor tyrosine kinase ErbB2 and is related with regulation of p27, we also compared the MUC4 expression with ErbB2 and p27 expressions in ICC-MFs. The patients with MUC4 and ErbB2 double positive expression showed a short survival period compared to non-expressing patients. MUC4 and p27 showed no relationship. The univariate analysis showed that tumor size, intrahepatic metastasis, lymph node metastasis, MUC4 expression, and MUC1 expression were statistically significant risk factors affecting the outcome of the patients with ICC-MF. The multivariate analysis demonstrated that MUC4 expression, as well as surgical margin, were statistically significant independent risk factors. In conclusion, the results suggest that expression of MUC4 in ICC-MF is a new independent factor for poor prognosis and is a useful marker to predict the outcome of the patients with ICC-MF.

Original languageEnglish (US)
Pages (from-to)220-229
Number of pages10
JournalHepatology
Volume39
Issue number1
DOIs
StatePublished - Jan 1 2004

Fingerprint

Cholangiocarcinoma
Mucin-4
Neoplasm Metastasis
Neoplasms
Receptor Protein-Tyrosine Kinases
Adenocarcinoma
Multivariate Analysis
Lymph Nodes
Immunohistochemistry
Ligands
Carcinoma
Survival
Liver

ASJC Scopus subject areas

  • Hepatology

Cite this

MUC4 Is a Novel Prognostic Factor of Intrahepatic Cholangiocarcinoma-Mass Forming Type. / Shibahara, Hiroaki; Tamada, Shugo; Higashi, Michiyo; Goto, Masamichi; Batra, Surinder Kumar; Hollingsworth, Michael A; Imai, Kohzoh; Yonezawa, Suguru.

In: Hepatology, Vol. 39, No. 1, 01.01.2004, p. 220-229.

Research output: Contribution to journalArticle

Shibahara, H, Tamada, S, Higashi, M, Goto, M, Batra, SK, Hollingsworth, MA, Imai, K & Yonezawa, S 2004, 'MUC4 Is a Novel Prognostic Factor of Intrahepatic Cholangiocarcinoma-Mass Forming Type', Hepatology, vol. 39, no. 1, pp. 220-229. https://doi.org/10.1002/hep.20031
Shibahara, Hiroaki ; Tamada, Shugo ; Higashi, Michiyo ; Goto, Masamichi ; Batra, Surinder Kumar ; Hollingsworth, Michael A ; Imai, Kohzoh ; Yonezawa, Suguru. / MUC4 Is a Novel Prognostic Factor of Intrahepatic Cholangiocarcinoma-Mass Forming Type. In: Hepatology. 2004 ; Vol. 39, No. 1. pp. 220-229.
@article{db6f0df6c22f494284bb762dfa92b175,
title = "MUC4 Is a Novel Prognostic Factor of Intrahepatic Cholangiocarcinoma-Mass Forming Type",
abstract = "Complete surgical resection of the tumor is the sole approach to improve the cure rate of patients with intrahepatic cholangiocarcinoma-mass forming type (ICC-MF). Although patients are treated by curative resection, many of them show poor outcome. Mucin (MUC)4 expression has been implicated as a marker for diagnosis and progression of pancreatic adenocarcinomas, but there is no study of the relationship between MUC4 expression and patient's prognosis in ICC-MF. In the present study, we examined the expression profile of MUC4 in ICC-MF tissue from 27 patients using immunohistochemistry. MUC4 was expressed in the carcinoma tissues of 10 (37{\%}) of the 27 ICC-MF tumors, whereas it was not expressed in normal liver tissue. Because MUC4 is an intramembrane ligand for receptor tyrosine kinase ErbB2 and is related with regulation of p27, we also compared the MUC4 expression with ErbB2 and p27 expressions in ICC-MFs. The patients with MUC4 and ErbB2 double positive expression showed a short survival period compared to non-expressing patients. MUC4 and p27 showed no relationship. The univariate analysis showed that tumor size, intrahepatic metastasis, lymph node metastasis, MUC4 expression, and MUC1 expression were statistically significant risk factors affecting the outcome of the patients with ICC-MF. The multivariate analysis demonstrated that MUC4 expression, as well as surgical margin, were statistically significant independent risk factors. In conclusion, the results suggest that expression of MUC4 in ICC-MF is a new independent factor for poor prognosis and is a useful marker to predict the outcome of the patients with ICC-MF.",
author = "Hiroaki Shibahara and Shugo Tamada and Michiyo Higashi and Masamichi Goto and Batra, {Surinder Kumar} and Hollingsworth, {Michael A} and Kohzoh Imai and Suguru Yonezawa",
year = "2004",
month = "1",
day = "1",
doi = "10.1002/hep.20031",
language = "English (US)",
volume = "39",
pages = "220--229",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - MUC4 Is a Novel Prognostic Factor of Intrahepatic Cholangiocarcinoma-Mass Forming Type

AU - Shibahara, Hiroaki

AU - Tamada, Shugo

AU - Higashi, Michiyo

AU - Goto, Masamichi

AU - Batra, Surinder Kumar

AU - Hollingsworth, Michael A

AU - Imai, Kohzoh

AU - Yonezawa, Suguru

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Complete surgical resection of the tumor is the sole approach to improve the cure rate of patients with intrahepatic cholangiocarcinoma-mass forming type (ICC-MF). Although patients are treated by curative resection, many of them show poor outcome. Mucin (MUC)4 expression has been implicated as a marker for diagnosis and progression of pancreatic adenocarcinomas, but there is no study of the relationship between MUC4 expression and patient's prognosis in ICC-MF. In the present study, we examined the expression profile of MUC4 in ICC-MF tissue from 27 patients using immunohistochemistry. MUC4 was expressed in the carcinoma tissues of 10 (37%) of the 27 ICC-MF tumors, whereas it was not expressed in normal liver tissue. Because MUC4 is an intramembrane ligand for receptor tyrosine kinase ErbB2 and is related with regulation of p27, we also compared the MUC4 expression with ErbB2 and p27 expressions in ICC-MFs. The patients with MUC4 and ErbB2 double positive expression showed a short survival period compared to non-expressing patients. MUC4 and p27 showed no relationship. The univariate analysis showed that tumor size, intrahepatic metastasis, lymph node metastasis, MUC4 expression, and MUC1 expression were statistically significant risk factors affecting the outcome of the patients with ICC-MF. The multivariate analysis demonstrated that MUC4 expression, as well as surgical margin, were statistically significant independent risk factors. In conclusion, the results suggest that expression of MUC4 in ICC-MF is a new independent factor for poor prognosis and is a useful marker to predict the outcome of the patients with ICC-MF.

AB - Complete surgical resection of the tumor is the sole approach to improve the cure rate of patients with intrahepatic cholangiocarcinoma-mass forming type (ICC-MF). Although patients are treated by curative resection, many of them show poor outcome. Mucin (MUC)4 expression has been implicated as a marker for diagnosis and progression of pancreatic adenocarcinomas, but there is no study of the relationship between MUC4 expression and patient's prognosis in ICC-MF. In the present study, we examined the expression profile of MUC4 in ICC-MF tissue from 27 patients using immunohistochemistry. MUC4 was expressed in the carcinoma tissues of 10 (37%) of the 27 ICC-MF tumors, whereas it was not expressed in normal liver tissue. Because MUC4 is an intramembrane ligand for receptor tyrosine kinase ErbB2 and is related with regulation of p27, we also compared the MUC4 expression with ErbB2 and p27 expressions in ICC-MFs. The patients with MUC4 and ErbB2 double positive expression showed a short survival period compared to non-expressing patients. MUC4 and p27 showed no relationship. The univariate analysis showed that tumor size, intrahepatic metastasis, lymph node metastasis, MUC4 expression, and MUC1 expression were statistically significant risk factors affecting the outcome of the patients with ICC-MF. The multivariate analysis demonstrated that MUC4 expression, as well as surgical margin, were statistically significant independent risk factors. In conclusion, the results suggest that expression of MUC4 in ICC-MF is a new independent factor for poor prognosis and is a useful marker to predict the outcome of the patients with ICC-MF.

UR - http://www.scopus.com/inward/record.url?scp=1442330985&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1442330985&partnerID=8YFLogxK

U2 - 10.1002/hep.20031

DO - 10.1002/hep.20031

M3 - Article

C2 - 14752841

AN - SCOPUS:1442330985

VL - 39

SP - 220

EP - 229

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 1

ER -